| API | Non pwodwi | KA NON. | Klasifikasyon |
| HQC23838 | Sulfapiridin | 144-83-2 | Antibyotik |
| PF-07321332 (dwòg pou Paxlovid) | (1R,2S,5S)-6,6-DIMETHYL-3-AZA-BICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIDE | 565456-77-1 | KOVID 19 |
| PF-07321333 (dwòg pou Paxlovid) | L-Valin, 3-methyl-N-(trifluoroacetyl)- (9CI) | 666832-71-9 | KOVID 19 |
| PF-07321334 (dwòg pou Paxlovid) | (αS,3S)-α-[(tèt-butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic asid Methyl Ester | 328086-60-8 | KOVID 19 |
| PF-07321335 (dwòg pou Paxlovid) | 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane | 943516-54-9 | KOVID 19 |
| PF-07321336 (dwòg pou Paxlovid) | Dimethyl (2S,4R)-2-(Boc-amino)-4-(cyanometil)pentandioat | 328086-57-3 | KOVID 19 |
| PF-07321337 (dwòg pou Paxlovid) | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide idroklorid | 25952-53-8 | KOVID 19 |
| PF-07321338 (dwòg pou Paxlovid) | 2-Idroksipiridin 1-oksid (HOPO) | 13161-30-3 | KOVID 19 |
| PF-07321339 (dwòg pou Paxlovid) | Idwoksid ityòm | 1310-65-2 | KOVID 19 |
| PF-07321340 (dwòg pou Paxlovid) | 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]piridinyòm 3-oksid hexafluorophosphate (HATU) | 148893-10-1 | KOVID 19 |
| apixaban | Asid acetic, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ester etilik | 27143-07-3 | Kadyovaskilè |
| apixaban | 3-Morpholino-1-(4-nitrofenil)-5,6-dihydropyridin-2(1H)-yon sèl | 545445-44-1 | Kadyovaskilè |
| Sacubitril | LCZ696 | 1426129-50-1 | Kadyovaskilè |
| Sacubitril | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tèt-butoxicarbonyl)aMino)-2-Methylpentanoic asid | 1012341-50-2 | Kadyovaskilè |
| Sacubitril | AHU377 | 149709-62-6 | Kadyovaskilè |
| Tikagrelor | 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)etanòl L-tatarik asid | 376608-65-0 | Kadyovaskilè |
| Tikagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium(2R)-hydroxy(phenyl)etanoate | 376608-71-8 | Kadyovaskilè |
| Tikagrelor | Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate | 220352-39-6 | Kadyovaskilè |
| Tikagrelor | 4,6-dikloro-2-propylthiopyrimidine-5-amine | 145783-15-9 | Kadyovaskilè |
| Quinapril | (S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic asid | 74163-81-8 | Kadyovaskilè |
| Rosuvastatin | Z-9: 4-(4-Fluorophenyl)-6-Izopropyl-2-[(N-methyl-N-methylsulfonyl)amino] pirimidinyl-5-yl-formyl | 147118-37-4 | Kadyovaskilè |
| Rosuvastatin | Z-7: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsufonyl)amino]pyrimidine-5-yl-methanol | 147118-36-3 | Kadyovaskilè |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-yonn | 438056-69-0 | Kadyovaskilè |
| Rivaroxaban | 5-Chlorothiophene-2-carboxylic asid | 24065-33-6 | Kadyovaskilè |
| Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phtalimid | 161596-47-0 | Kadyovaskilè |
| Klopidogrel | Thiophene-2-etanòl | 5402-55-1 | Kadyovaskilè |
| Klopidogrel | 4,5,6,7-Tetrahydro-thieno [3,2-c]piridin HCl | 28783-41-7 | Kadyovaskilè |
| Patiromer | Methyl 2-fluoroacrylate | 2343-89-7 | Kadyovaskilè |
| Ezetimibe | (3R,4S)-4-(4-(Benzyloxy)Phenyl)-1-(4-Fluorophenyl)-3-((S)-3-(4- Fluorophenyl)-3-Hydroxypropyl)Azetidin-2-One | 163222-32-0 | Kadyovaskilè |
| Fenofibrat | Fenofibrate asid: (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropionic asid) | 42017-89-0 | Kadyovaskilè |
| Edoxaban | Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate idroklorid | 1243308-37-3 | Kadyovaskilè |
| Edoxaban | 5-Methyl-4,5,6,7-tetrahydrothiazolo [5,4-c] pyridine-2-carboxylic asid idroklorid | 720720-96-7 | Kadyovaskilè |
| Edoxaban | Tert-Butil (1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate asid oksalik | 1353893-22-7 | Kadyovaskilè |
| donatè | 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]piridin-3-karbonitrile | 1350653-26-7 | Kadyovaskilè |
| Sotagliflozin | 4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzèn | 1103738-29-9 | dyabèt |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene) -1-C-4-Morpholinyl-, (5S)- | 1103738-19-7 | dyabèt |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-4,5-O-(1-Methylethylidene)-, (5S) - | 1103738-30-2 | dyabèt |
| Sotagliflozin | 5-bromo-2-chloro-4'-ethoxydiphenylmethane | 461432-23-5 | dyabèt |
| Kanagliflozin | 2-(4-FLUOROFENIL)TIOFÈN | 58861-48-6 | dyabèt |
| Kanagliflozin | 5-Bromo-2-methylbenzoic asid | 79669-49-1 | dyabèt |
